A 04 day virtual training 26-29 October 2020 on “Quality Assurance for Drug Demand Reduction Services in Pakistan” kicked off by United Nations Office on Drugs and Crime (UNODC) to support the Pakistan government in meeting global standards...
Five-day online regional refresher training for assessors on UNODC-WHO quality assurance (QA) tools for drug dependency treatment launched on 12 October 2020. The purpose of the training is to consolidate the institutional support to ensure...
Background
In 2019, four Central Asian countries – Kazakhstan, Kyrgyzstan, Tajikistan and Uzbekistan – piloted the implementation of UNODC's quality assurance mechanisms/tools for the treatment of drug use disorders.
The event was held...
Background
Four Central Asia countries piloted the UNODC Quality Assurance (QA) mechanisms in 2019 with training and technical assistance provided by UNODC in 2018-2019. The countries involved were Tajikistan, Kazakhstan, Uzbekistan and...
More than 25 Kenyan policymakers participated in a five-day UNODC policymakers online training on the nature, prevention and treatment of drug use disorders, held between 24 and 31 August 2020. The aim of this high-level training is to...
In this brochure, the EMCDDA's Scientific Director takes us on a journey through 25 years of annual reporting on the drugs problem in Europe.
The journey begins with the first report describing the drug situation in 1995 and leads us, over...
COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug...
According to the UN High Commissioner for Refugees (UNHCR) there are now close to 80 million forcibly displaced people worldwide, and with mental health among this segment of the world’s population already a neglected area, the treatment...
This webinar explored how regulations put in place to prevent the spread of COVID-19 are inadvertently contributing to an increasingly toxic illegal drug supply and how this shift has both increased health harms and created policy...
